Parathyroid hormone levels: the lower the better the outcomes

Hirotaka Komaba

doi:10.1097/mnh.0000000000001188

April 30, 2026Current Opinion in Nephrology & Hypertension

Parathyroid hormone levels: the lower the better the outcomes

View Full Paper

Ask AI

Bookmark

Share

Key Points

This review examines the effectiveness of intensive parathyroid hormone control in managing secondary hyperparathyroidism in chronic kidney disease.
Review of recent findings on parathyroid hormone management in chronic kidney disease patients.
Analysis of risks associated with intensive PTH suppression and its effects on bone integrity.
Evaluation of the effects of calcimimetics in managing secondary hyperparathyroidism.
Intensive PTH reduction may not impair bone integrity and could lower fracture risk.
Early intervention is crucial to limit cortical porosity progression related to secondary hyperparathyroidism.
Calcimimetics have a limited impact on low-turnover bone and vascular calcification in patients.

Implication

Review uncovers that aggressive reduction of parathyroid hormone improves skeletal integrity in chronic kidney disease, suggesting enhanced fracture risk management.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Hirotaka Komaba (2026) studied this question.

synapsesocial.com/papers/69faa30204f884e66b5338af https://doi.org/10.1097/mnh.0000000000001188

View Full Paper

Ask AI

Bookmark

Share

Parathyroid hormone levels: the lower the better the outcomes

Key Points

Implication

Discussion

Cite This Study

Parathyroid hormone levels: the lower the better the outcomes

Key Points

Implication

Discussion

Cite This Study

Keep reading

Keep reading